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KObjective: To evaluate the incidence of postoperative
trial fibrillation (POAF), the predisposing factors, the re-
ults of treatment before discharge, and the impact on du-
ation and costs of hospitalization.
Design: A prospective observational study.
Methods: Patients who underwent cardiac surgery from
anuary 1, 2007 to December 31, 2007.
Interventions: Electrocardiography was continuously
onitored after surgery. Patients with symptomatic new-
nset atrial fibrillation or lasting >15 minutes were treated
ith amiodarone and with DC shock in prolonged cases.
Results: POAF occurred in 29.7%, with the higher inci-
ence between the 1st and 4th postoperative day. Age (p <
.001), atrial size >40 mm (p < 0.001), previous episodes of
F (p < 0.001), female sex (p  0.010), and combined valveardiac surgery between January 2007 and December 2007, 28 patients
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ournal of Cardiothoracic and Vascular Anesthesia, Vol xx, No x (Month),f POAF at logistic regression. Sinus rhythm was restored
y early treatment in 205 of 215 patients. This was associ-
ted with a low incidence of cerebrovascular events (<0.5%)
nd with a limited increase of average length of hospitaliza-
ion (24 hours) in patients with POAF.
Conclusions: The overall incidence of POAF in the authors’
enter is close to 30%; 95.3% of patients were discharged in
inus rhythm. The increase in length and costs of hospitaliza-
ion (on average, 1.0 day with a burden of about €1,800/
atient) were significantly lower than in previous investiga-
ions.
2010 Elsevier Inc. All rights reserved.
EY WORDS: atrial fibrillation, perioperative complications,
nd bypass surgery (p  0.012) were multivariate predictors cardiac surgery, amiodaroneHE INCIDENCE OF atrial arrhythmias after cardiac surgery
ranges between 10% and 65%.1,2 A meta-analysis comprising
4 studies reported postoperative atrial fibrillation (POAF) in 30%
f cases after coronary artery bypass graft (CABG) surgery.3 The
ncreasing age of patients undergoing cardiac surgery is signifi-
antly associated with an increased risk of POAF.4-6 Several
actors, including the type of surgical procedure, patient demo-
raphics, criteria used for diagnosis, and methods of electrocar-
iographic (ECG) monitoring, may account for the wide range of
OAF incidence reported in the literature.7-9 POAF is near 10%
hen the diagnosis is based on scheduled 12-lead ECGs, but more
han 40% when continuous ECG recording or Holter monitoring
re used and episodes lasting less than 10 minutes7,8 are included
n the analysis. Otherwise, the incidence of POAF has been
eported to range between 16% and 30% when the diagnosis is
ade on the basis of patients’ symptoms.10,11 At present, there is
o definite evidence regarding the clinical weight of POAF-related
linical complications in patients suffering from symptomatic ver-
us asymptomatic atrial fibrillation (AF), and further studies are
eeded to clarify the question.
Previous investigations suggested that POAF is associated with
ncreased hospital mortality and morbidity, in particular a higher
ncidence of stroke, up to 3 times more in comparison with patients
ith stable sinus rhythm, and an increase in the length of hospitaliza-
ion.12-14 Heart rate control instead of an early attempt to restore sinus
hythm is usually the strategy of choice in patients with POAF, and
ittle information exists on the effects of early recovery of sinus
hythm on POAF-related complications.7 Therefore, to improve
OAF management, the authors set out to (1) determine the preva-
ence and timing of perioperative AF, (2) identify its risk factors, (3)
valuate treatment strategies, (4) assess return to sinus rhythm by
ospital discharge, (5) investigate its impact on outcomes, and (6)
valuate its economic implications.
PATIENTS AND METHODS
A 1-year survey was planned. Among 822 patients who underwentho died during the perioperative period and 69 suffering from chronic
F and/or undergoing the maze procedure were excluded from the
nalysis. In the study, 725 patients, 482 men and 243 women (mean
ge, 67.4  12 years), were finally included. Surgical procedures are
hown in Figure 1. Echocardiographic evaluation was performed 48
ours before surgery using a Sequoia Acuson Instrument (Siemens
edical Solution, CA) according to the guidelines of the American
ociety of Echocardiography.15
Table 1 shows baseline clinical and echocardiographic patient char-
cteristics. Oral drugs were administered up to 12 hours before surgery
nd resumed 12 hours after intensive care unit (ICU) admission, clin-
cal conditions permitting, through a nasogastric tube if necessary.
The primary endpoint was the development of AF. All patients had
ontinuous ECG monitoring in the ICU and were subsequently dis-
harged to a monitored unit throughout their hospital stay. Atrial
rrhythmias were identified according to the Society of Thoracic Sur-
eons’ definition as those that were clinically documented or treated.
bserved atrial arrhythmias were AF and atrial flutter, and, unless
therwise stated, the authors use “AF” to mean either. Indeed, all
ymptomatic episodes of AF confirmed by ECG recording or asymp-
omatic AF revealed by continuous ECG monitoring lasting more than
0 minutes were considered as POAF and included in the analysis.
Secondary endpoints included discharge rhythm, length of postoperative
tay, and incidence of postoperative complications. Discharge rhythm was
dentified as normal sinus rhythm (NSR), AF, or atrial flutter.
Transient electric stimulation through epicardial wires was used for
evere bradycardia or atrioventricular block until the restoration of
eart rhythm or definitive pacemaker implant. Patients who did not
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ence, Italy; †Department of Cardiac Surgery, Academic Hospital,
aastricht, The Netherlands; and ‡Department of Heart and Vessels,
areggi Hospital, Florence, Italy.
Address reprint requests to Carlo Rostagno, MD, PhD, Dipatimento
rea Critica, Università di Firenze, Firenze 50134, Italy. E-mail:
.rostagno@katamail.com
© 2010 Elsevier Inc. All rights reserved.
1053-0770/xx0x-0001$36.00/0
doi:10.1053/j.jvca.2010.03.009
12010: pp xxx
ra
c
c
c
w
c
d
i
i
P
c
g
n
n
e
(
c
g
o
e
s
p
S
d
d
A
o
r
e
v
t
(
s
f
t
s
v
T
p
t
(
T
a
w
d
m
o
(
w
w
(
p
t
r
p
(
I
u
u
(
i
c
r
h
(
a
l
1
w
I
d
s
i
2 ROSTAGNO ET AL
ARTICLE IN PRESSecover NSR within 30 minutes usually were treated with intravenous
miodarone (300 mg in 1 hour followed by 900 mg/24 hours IV
ontinuous infusion) to control heart rate. Propafenone was used in
ases of known previous amiodarone-related side effects. Electrical
ardioversion by biphasic DC shock was considered when sinus rhythm
as not restored after 24 hours of pharmacologic treatment. Electrical
ardioversion was performed on a selective basis in 39 patients. Car-
ioversion was begun at 200 J and was performed according to Amer-
can College of Cardiology recommendations.16
In-hospital costs were obtained from the hospital’s financial account-
ng department. All billed items associated with the occurrence of
OAF were assigned to one of the following categories: anesthesia:
ost of anesthetics, equipment, and disposables used by anesthesiolo-
ists during electric cardioversion; intensive care unit: cost/day of
ursing, equipment, and space in the ICU (total  cost/d 
umber of extra days); subintensive care unit ward: cost of nursing,
quipment, and space in the subintensive care unit and in the ward
total cost/d number of extra days); laboratory: cost of blood tests;
ardiology laboratory: cost of electrocardiograms and echocardio-
rams; pharmacy: cost of pharmacy; therapies: cost of physical and
ccupational therapies; and others: unknown and nonspecified costs.
Following the World Medical Association Guidelines concerning
thical principles for medical research involving human subjects,5 the
tudy was approved by the Institutional Ethics Boards. Furthermore, all
atients gave their informed consent.
Variables were tested for normal distribution by the Kolmogorov-
mirnov test. Continuous variables were presented as mean and stan-
ard deviation, categoric variables as percentage, and non-normally
istributed variables as median and interquartile range. The timing of
F was calculated as the interval from the date of surgery to the date
f developing AF. The time-related risk of AF was estimated paramet-
ically by a multiphase hazard decomposition method.17
Categoric variables were compared with the chi-square or Fisher
xact test. Student t tests (unpaired) were used to compare continuous
ariables except when data were skewed; in which case, the Wilcoxon
est was used. Variables reaching statistical significance or borderline
Fig 1. The number of interventions performed in the period under
nvestigation.0.1) were introduced in multivariate analysis. aMultivariate logistic regression analysis by means of a backward
tepwise algorithm (cutoff for entry 0.05, for removal 0.10) was per-
ormed to select independent predictors of early death and postopera-
ive events. Categoric variables with more than 2 levels in the regres-
ion model were converted into dummy variables. Thirty-eight
ariables (Appendix 1) were chosen based on existing Society of
horacic Surgeons risk-adjustment models and investigated for their
redictive value. Nonetheless, to enhance the accuracy of the model,
he number of variables were reduced using variable clustering18
PROC-VARCLUS;SAS/STAT, release 9; SAS Institute, Cary, NC).
he appropriateness of fit of the final logistic regression models was
ssessed with the Hosmer-Lemeshow statistic, and predictive accuracy
as assessed by the concordance index.19 Internal validation of pre-
ictors generated by multivariate logistic regression was performed by
eans of bootstrapping techniques, with 1,000 cycles and generation of
dds ratios and bias-corrected 95% confidence interval.20 SPSS 12.0
SPSS, Chicago, IL) and Stats Direct 2.5.7 (Stats Direct, Sale, UK)
ere used for these calculations. Significance for hypothesis testing
as set at the 0.05 2-tailed level.
RESULTS
POAF developed in 215 patients (29.7%). Thirty-nine
4.1%) had preoperative episodes of AF. The incidence of AF
eaked 2 days after the procedure (4.14%/d [standard error of
he mean, 3.47-4.90]) and declined steadily thereafter (Fig 2).
Patients with POAF were older than patients without ar-
hythmic complications (71.0  8.9 years v 66.4  6.5 years,
 0.001). Furthermore, POAF was more frequent in females
106/243 [33.3%]) than in males (134/482 [27.8%], p 0.049).
n addition, POAF was significantly less frequent in patients
ndergoing isolated CABG surgery (23.5%) than in patients
ndergoing associated CABG surgery and valve procedures
42.2%, p  0.001). The occurrence of POAF was not signif-
cantly different in off-pump coronary artery bypass grafting
ompared with on-pump CABG surgery (23.4% and 22%,
espectively; p  0.9). Moreover, patients developing POAF
ad more frequent episodes of AF in the preoperative period
18.4% v 37.3%, p  0.001).
In addition, subjects who experienced POAF had a larger left
trial diameter (38.2 1.4 v 43.3 2.6, p 0.001) and a lower
eft ventricular ejection fraction (42.4%  12% v 54.2% 
5%, p  0.005). Regarding postoperative variables, patients
ith POAF underwent prolonged use of catecholamines in the
CU (2.5  0.9 hours v 5.9  1.2 hours, p  0.001). Preop-
Table 1. Baseline Clinical and Echocardiographic Characteristics
Sex M/F 482/243 (66.5/33.5)
Age (years  standard deviation) 67.4  12.3
Hypertension 428 (59%)
PAF history 39 (5.37%)
LA diameter (mm) 41.65  6.3
LVEF (%) 52.26  10.5
-Blockers 288 (39.72%)
ACE inhibitors or AT1 blocker 469 (64.69%)
Statins 276 (38.06%)
NOTE. Continuous variables are presented as mean  standard
eviation. Discrete variables are presented as percentage (parenthe-
es).
Abbreviations: M/F, male/female; PAF, preoperative AF; LA, lefttrium; LVEF, left ventricular ejection fraction.
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3ATRIAL FIBRILLATION AND CARDIAC SURGERY
ARTICLE IN PRESSrative use of -blockers (p  0.06), angiotensin-converting
nzyme (ACE) inhibitors (or AT1-receptor blockers, p  0.4)
r statins (p  0.2) failed to show a predictive value on POAF
or univariable analysis.
For multivariate analysis, age was a strong predictor of
OAF (p  0.001, Table 2). Indeed, patients older than 80
ears had 39.3% higher probability than patients aged 70 to 80
ears and 98.4% higher probability than patients younger than
0 years (Fig 3). In addition, atrial size 40 mm (p  0.001)
nd previous episodes of AF in the preoperative period (p 
.001) significantly increased the likelihood of developing
OAF. Finally, female sex (p  0.010) and combined valve
nd bypass surgery (p  0.012) were multivariate predictors of
OAF at logistic regression.
One hundred ninety patients (92.7%) underwent pharmaco-
ogic treatment consisting of rate-control agents only in 4
2.1%), antiarrhythmics only in 163 (85.8%), and both in 23
12.1%). Rate-control agents included metoprolol, carvedilol,
iltiazem, propafenone, and digoxin; amiodarone was the only
hythm-control agent used. Electrical cardioversion was used in
7 patients (31.1%), of whom 28 (41.7%) had undergone
revious unsuccessful pharmacologic treatment.
At discharge, 95.3% (205/215) of patients with POAF were
Fig 2. The incidence of AF after cardiac surgery (hazard function).
he solid line is the parametric estimate, and dashed lines are 68%
onfidence limits, equivalent to 1 standard error.
Table 2. Multivari
Variable B St. Err
Intercept 1.648 0.57
Age 80 y 1.516 0.309
Atrial size 40 mm 1.429 0.296
Valve surgery  CABG 1.010 0.403
Preoperative episodes of AF 1.516 0.309
Female sex 0.988 0.393
NOTE. Hosmer and Lemeshow  0.729; concordance index  0.8.
Abbreviations: B, regression coefficient; CI, bias-corrected confidence inn NSR. In 15 (7.3%), sinus rhythm was restored spontaneously
ithin 30 minutes. Among patients who required pharmaco-
ogic treatment, 85.8% (140/163) receiving only amiodarone
nd 73.9% (17/23) undergoing combined rate control and an-
iarrhythmic therapy recovered sinus rhythm.
Among patients undergoing cardioversion, 59.7% (40/67)
equired 1 DC shock, 25.4% (17/67) 2, and 14.9% (10/67) 3 or
ore attempts. The overall cardioversion success rate was 94%
63/67). Ten patients (4.6%) were discharged in atrial fibrilla-
ion. Among them, 4 had only pharmacologic therapy, whereas
had cardioversion after unsuccessful pharmacologic treat-
ent. All these patients had undergone valve surgery and were
ischarged with antiarrhythmic therapy associated with digoxin
nd warfarin.
Patients in whom AF developed postoperatively had a longer
edian length of hospital stay (7.9 days; interquartile range,
.5-9.5) than those who did not have AF (5.7 days; interquartile
ange, 3.6-7.1; p  0.001 [Fig 4]). No difference in hospital
ncidence of cerebrovascular events was found between pa-
ients with POAF compared with patients with stable sinus
hythm (0.45% v 0.41%, p  0.9).
Total costs (Table 3) were higher in the POAF group (plus
;1,800 [1,599-2,302], p  0.001), with the largest increases in
he ICU (p 0.02), subintensive care unit ward (p 0.001),
aboratory (p  0.004), and cardiology laboratory (p  0.01).
edictors of POAF
Wald p Ex(B) 95% CI
8.339 0.004 — —
24.109 0.001 4.552 2.486-8.335
23.388 0.001 4.175 2.339-7.451
6.276 0.012 2.746 1.246-6.055
24.109 0.001 4.512 2.486-8.335
6.378 0.010 2.685 1.243-5.798
Fig 3. The predictive value of age at multivariate logistic regres-
ion. Data are expressed as odds ratio and 95% bias-corrected con-
dence interval.ate Prterval.
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4 ROSTAGNO ET AL
ARTICLE IN PRESSDISCUSSION
AF is the most frequent complication after cardiac surgery.2
revious investigations reported increased morbidity and mortality
elated to POAF.3,21 Moreover, POAF was associated with signif-
cant increases in duration and the overall costs of hospitaliza-
ion.14,22 Mathews et al21 reported that the overall incidence of
OAF was 27% in 2,417 patients undergoing CABG surgery with
r without concurrent valve surgery. In a study by the Department
f Veterans Affairs,23 similar results were reported. Mitral valve
epair or replacement significantly increased the risk of AF (odds
atio  2.88 and 2.33, respectively).
In the present investigation, the overall incidence of POAF
as close to 30%, which was not significantly different from
hat reported in previous studies.24,25 With multivariate logistic
egression analysis, the present results suggest that age, atrial
ize 40 mm (p  0.001), previous episodes of AF (p 
.001), female sex (p 0.010), and combined valve and bypass
urgery (p  0.012) significantly increased the likelihood of
eveloping POAF.
Patients undergoing valve surgery, in particular when asso-
iated with coronary revascularization, were twice as likely to
evelop POAF compared with patients undergoing CABG sur-
ery, which is in agreement with previously reported data.26 In
atients undergoing surgical revascularization, the authors did
ot find any significant difference between patients undergoing
ardiopulmonary bypass (CPB) surgery versus off-pump surgery
23.4% v 22%). It has been hypothesized that intraoperative
schemia related to hemodynamic changes during CBP plays a
ole in the development of POAF; it was suggested that the
ecreased risk of ischemic damage in beating-heart CABG
urgery reduced its incidence. Initial favorable results27,28 were
ot confirmed by other authors who failed to find a relation
etween the techniques of CABG surgery.29,30
Independent predictors of POAF included advanced age, female
ex, a history of AF or of congestive heart failure, and the incidence
f POAF.21-23 Age is the independent variable most consistently
ssociated with POAF.31-33 In the present investigation, 62.6% of
OAF patients were aged 70 years. Aranki et al34 report an 18%
ncidence of POAF in patients aged60 years versus 52% for those
Fig 4. The length of hospital stay in patients with and without
OAF. (Data are expressed as median and interquartile range.)ged 80 years. The probability of developing POAF increases by about 25% for every 5-year increase in age,32 with a plateau after 80
ears.13 Because the incidence of AF also increases with age in
medical” AF, age-related degenerative and inflammatory changes in
trial anatomy may induce modifications of electophysiologic prop-
rties of atrial myocytes that may advance the onset of the arrhyth-
ia.35,36
Surgical variables that may advance atrial ischemia, such as the
uration of aortic cross-clamping and the time of the recovery of atrial
lectrical activity after cardioplegia, have been shown to be indepen-
ently related to the risk of POAF.12,37,38 In accordance with previous
tudies,38,39 a history of paroxysmal AF was associated with a 2 to 3
imes higher risk of POAF. An increased left atrial diameter and a
ower LVEF were significantly associated with an increased risk of
OAF as suggested previously.40 Several studies, however, failed to
nd a clear relation between atrial enlargement and postoperative
F.41,42
Acute stretching of atrial fibers caused by an abrupt increase
n left atrial pressure may favor dispersion of refractoriness
ith a higher risk of AF.43 Chronic atrial dilation caused by
alvular disease or left ventricular dysfunction is associated
ith anatomic changes, mainly foci of fibrosis, which may lead
o atrial “electric remodeling.”
Almassi et al18 showed that the use of inotropic agents for
ore than 30 minutes after the termination of CPB was asso-
iated with a higher incidence of arrhythmias; the risk of POAF
xceeded 50% in patients with cardiogenic shock undergoing
urgical revascularization.44 In the present study, 14% of pa-
ients with POAF had severe postoperative hemodynamic
mpairment requiring prolonged administration of cat-
cholamines, in comparison to 5.7% of patients without ar-
hythmia complications (p  0.005). The relative proarrhyth-
ic effect of a severe hemodynamic impairment per se and that
f sympathicomimetic drugs in the development of POAF
emain to be clarified. POAF has been reported to be associated
ith a longer hospital stay and with a higher risk of infectious,
enal, and neurologic complications.45-47 Moreover, discharge
rom the hospital before the restoration of sinus rhythm has
Table 3. Extra Costs in Patients With POAF (in Euros)
Anesthesia 80 (30-95)
Intensive care unit 180 (138-223)
Subintensive care unit  ward 830 (770-1,030)
Laboratory 293 (250-328)
Cardiology laboratory 265 (235-312)
Pharmacy 130 (102-175)
Therapies 78 (46-84)
Other 44 (28-55)
Total cost 1,800 (1,599-2,302)
NOTE. Costs are presented as median and interquartile range.
nesthesia: cost of anesthetics, equipment, and disposables used by
nesthesiologists during electric cardioversion; intensive care unit:
ost/d of nursing, equipment, and room in the intensive care unit
total cost/d number of extra days); subintensive care unitward:
ost of nursing, equipment, and room in the subintensive care unit
nd in the ward. Total  cost/d  number of extra days; laboratory:
ost of blood examinations; cardiology laboratory: cost of electrocar-
iograms and echocardiograms; pharmacy: cost of pharmacy; thera-
ies: cost of physical and occupational therapies; others: unknown
nd nonspecified costs.
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5ATRIAL FIBRILLATION AND CARDIAC SURGERY
ARTICLE IN PRESSeen associated with a high incidence of persistence of arrhyth-
ia. In the study of Loubani et al,46 39% still had AF 6 months
fter surgery despite the use of antiarrhythmic medication. This
bservation emphasizes the need for a close follow-up in pa-
ients discharged in AF and a scheduled attempt at electrical
ardioversion after an adequate period of anticoagulation in the
ase of persistence of AF.
Early restoration of sinus rhythm before discharge, usually within
4 hours from the onset of the arrhythmia, avoids the need for
ransesophageal echocardiography before DC shock and reduces the
isk and the costs of prolonged anticoagulation and those for rehos-
italization for elective electrical cardioversion. According to the
uthors’ protocol, all patients in whom AF lasted30 minutes were
reated with amiodarone and, in the case of failure of drug treatment,
ith DC shock. Less than 5% (10/214) of patients were discharged in
F. Prompt restoration of sinus rhythm may account for the low
ncidence of neurologic complications (only 1 stroke was observed in
ach group). Moreover, early restoration of NSR is likely to decrease
he lengthening and overall costs of hospitalization independently
ttributable to POAF. Aranky et al34 reported a duration of hospital-
zation in patients with POAF an average of 3 to 4 days longer than
n patients in NSR, which is on average 2 days more than that
bserved in the present study. Similar results were reported by other
uthors, with additional attributable costs associated with POAF rang-
ng from $5,000 to $12,000 per patient.14,22,47
A recent investigation has shown that an exaggerated
nflammatory response is associated with a higher risk of
OAF.48,49 The release of cytokines and an increase in
xidative stress with elevated atrial levels of peroxynitrite
ay affect the activity of sodium channels,50 whereas inter-
eukin 2 and free radicals decrease the upstroke velocity of
he action potential by reducing sodium currents.51 Finally,
he tumor necrosis factor downregulates gap junction pro-
eins and reduces cell coupling.52 These electrophysiologic
hanges may result in nonhomogeneity of atrial conduction
nd favor POAF. The present authors failed to find any
elationship between clinical and ECG signs of pericardial
nvolvement and the risk of POAF, although the role of
nflammation may be significantly underestimated by simple
linical evaluation.
Several investigations evaluated the effectiveness of phar-
acologic and nonpharmacologic interventions for the preven-
ion of AF, with the main purpose of decreasing the length of
ospital stay and the risk of POAF-related stroke.53,54 -Blocker
ithdrawal before surgery was associated with a higher risk of
OAF; conversely, continuation of treatment decreased the
ncidence of arrhythmic complications.21 Similarly, Mathew et
l26 suggested that preoperative treatment with inhibitors of the
enin-angiotensin system was associated with a decreased risk
f postoperative AF. Contrasting results were reported by
oleman et al.55
Results from the present investigation failed to show that
OAF incidence was influenced by perioperative treatment
ith -blockers, ACE inhibitors, or AT1 blockers or statins. It
ust be emphasized that prophylactic treatment with -block-
rs has been investigated extensively in patients undergoing
ardiac surgery without contraindications to the drugs53; the
ncidence of POAF was decreased by active treatment from
3% in the control group to 19% in the -blockers group. Even pf single studies showed a marked heterogeneity in the type and
osage of drugs used, the administration protocol, size of the
ample under study, and criteria used for the diagnosis of AF,
linical results were not significantly influenced by these vari-
bles. Regarding the effects of ACE inhibitors or AT1-blockers
n the prevention of postsurgery AF, no randomized studies
ave been published. Finally, it has been suggested that POAF
as less frequent and its duration shorter in patients treated
ith statins in comparison with a nonstatin group,56,57 and
ssociated with a decrease in inflammatory markers.
The exact mechanisms by which statins may reduce POAF
re unclear. Modulation of remodeling of the cardiac extracel-
ular matrix and of the inflammatory response as shown by
ecreased markers of inflammation, including C-reactive pro-
ein, serum amyloid A, tumor necrosis factor , and interleu-
in-6, may play a role in the statin protective action.58,59 Re-
ently, the ARMYDA-3 study60 randomized 200 patients
ithout a history of AF undergoing CPB surgery with atorva-
tatin, 40 mg/d, or placebo, starting 7 days before surgery.
tatins decreased POAF incidence from 57% to 35%, as they
id the length of hospitalization. The contribution of oxidative
tress in the pathogenesis of POAF is strengthened by the
bservation of a 50% decrease in AF in patients treated with
itamin C for 5 days after surgery.61
CONCLUSIONS
Results from the present investigation confirm that despite
he progress in anesthesiology and surgical techniques the
ncidence of POAF has not shown significant changes in the
ast 2 decades. Conversely, the present data support the hypoth-
sis that early treatment enables the restoration of sinus rhythm
efore discharge in more than 95% of patients, and this factor
s associated with decreases in clinical complications and eco-
omic costs related to the development of the arrhythmia. The
resent results, although not comparable with randomized stud-
es, failed to show any significant difference in POAF incidence
n patients treated with -blockers, ACE inhibitors, or AT1
lockers or statins. Further studies are needed to evaluate if
ombined treatment aimed at decreasing oxidative stress and
tabilizing membrane channels could decrease the incidence of
ostoperative AF.
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APPENDIX 1 VARIABLES TESTED IN UNI- AND
MULTIVARIATE ANALYSIS
reoperative Variables
Age 80 years, age 70 to 80, age 70, sex, previous
pisodes of AF, body surface area 1.95 m2, obesity, smoking,
ypertension, diabetes mellitus, impaired renal function (plasma
reatinine 2 mg/dL), hemodialysis, chronic obstructive pul-
onary disease, need for preoperative intra-aortic balloonump, left ventricular ejection fraction 35%, left atrial di-
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6 ROSTAGNO ET AL
ARTICLE IN PRESSension 40 mm, preoperative use of -blockers, use of
-blockers, ACE inhibitors or statins, preoperative serum K.
perative Variables
Urgent/emergent operation, CABG surgery, off-pump
ABG surgery, complete arterial revascularization, isolated
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Return to the intensive care unit, reoperation, prolonged me-
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atecholamines in the intensive care unit, prolonged electrical stim-
lation by epicardial wires for bradycardia, or transient AV block.REFE
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